메뉴 건너뛰기




Volumn 7, Issue 10, 2010, Pages 538-539

Infection: Bismuth improves PPI-based triple therapy for H. pylori eradication

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; BISMUTH; CLARITHROMYCIN; METRONIDAZOLE; OMEPRAZOLE; PROTON PUMP INHIBITOR; TETRACYCLINE;

EID: 77957739590     PISSN: 17595045     EISSN: 17595053     Source Type: Journal    
DOI: 10.1038/nrgastro.2010.131     Document Type: Short Survey
Times cited : (52)

References (11)
  • 1
    • 77952151766 scopus 로고    scopus 로고
    • High efficacy of 14-day triple therapy-based, bismuth-containing quadruple therapy for initial H. pylori eradication
    • Sun, Q. et al. High efficacy of 14-day triple therapy-based, bismuth-containing quadruple therapy for initial H. pylori eradication. Helicobacter 15, 233-238 (2010).
    • (2010) Helicobacter , vol.15 , pp. 233-238
    • Sun, Q.1
  • 2
    • 48249142046 scopus 로고    scopus 로고
    • A clinical study of proton pump inhibitor-containing quadruple regimen as first-line therapy for H. pylori eradication
    • Mu, F., Hu, F., Yang, G. & Cheng, H. A clinical study of proton pump inhibitor-containing quadruple regimen as first-line therapy for H. pylori eradication. Chin. J. Gastroenterol. 12, 531-534 (2007).
    • (2007) Chin. J. Gastroenterol. , vol.12 , pp. 531-534
    • Mu, F.1    Hu, F.2    Yang, G.3    Cheng, H.4
  • 3
    • 33846152938 scopus 로고    scopus 로고
    • Comparison of efficacy of 7-day rabeprazole-based triple therapy versus quadruple therapy for treatment of Helicobacter pylori infection
    • Zheng, Q., Pan, Y., Zhang, L. & Xiao, S. Comparison of efficacy of 7-day rabeprazolebased triple therapy versus quadruple therapy for treatment of H. pylori infection. Chin. J. Gastroenterol. 11, 645-647 (2006). (Pubitemid 46075697)
    • (2006) Chinese Journal of Gastroenterology , vol.11 , Issue.11 , pp. 645-647
    • Zheng, Q.1    Pan, Y.2    Zhang, L.3    Xiao, S.4
  • 4
    • 0034954931 scopus 로고    scopus 로고
    • What is the optimal length of proton pump inhibitor-based triple therapies for H. pylori? A cost-effectiveness analysis
    • Calvet, X., Gené, E., López, T. & Gisbert, J. P. What is the optimal length of proton pump inhibitor-based triple therapies for H. pylori? A cost-effectiveness analysis. Aliment. Pharmacol. Ther. 15, 1067-1076 (2001).
    • (2001) Aliment. Pharmacol. Ther. , vol.15 , pp. 1067-1076
    • Calvet, X.1    Gené, E.2    López, T.3    Gisbert, J.P.4
  • 5
    • 35848963397 scopus 로고    scopus 로고
    • Meta-analysis: Duration of firstline proton-pump inhibitor based triple therapy for H. pylori eradication
    • Fuccio, L. et al. Meta-analysis: duration of firstline proton-pump inhibitor based triple therapy for H. pylori eradication. Ann. Intern. Med. 147, 553-562 (2007).
    • (2007) Ann. Intern. Med. , vol.147 , pp. 553-562
    • Fuccio, L.1
  • 6
    • 34147206129 scopus 로고    scopus 로고
    • Comparison of 1 and 2 weeks of omeprazole, amoxicillin and clarithromycin treatment for H. pylori eradication: The HYPeR study
    • Zagari, R. M. et al. Comparison of 1 and 2 weeks of omeprazole, amoxicillin and clarithromycin treatment for H. pylori eradication: The HYPeR study. Gut 56, 475-479 (2007).
    • (2007) Gut , vol.56 , pp. 475-479
    • Zagari, R.M.1
  • 7
    • 72949096113 scopus 로고    scopus 로고
    • Sequential therapy or triple therapy for H. pylori infection: Systematic review and metaanalysis of randomized controlled trials in adults and children
    • Gatta, L., Vakil, N., Leandro, G., Di Mario, F. & Vaira D. Sequential therapy or triple therapy for H. pylori infection: systematic review and metaanalysis of randomized controlled trials in adults and children. Am. J. Gastroenterol. 104, 3069-3079 (2009).
    • (2009) Am. J. Gastroenterol. , vol.104 , pp. 3069-3079
    • Gatta, L.1    Vakil, N.2    Leandro, G.3    Di Mario, F.4    Vaira, D.5
  • 8
    • 72949121483 scopus 로고    scopus 로고
    • Sequential therapy for eradication of H. pylori: A new guiding light or a false dawn?
    • Moayyedi, P. & Malfertheiner, P. editorial
    • Moayyedi, P. & Malfertheiner, P. editorial: sequential therapy for eradication of H. pylori: a new guiding light or a false dawn? Am. J. Gastroenterol. 104, 3081-3083 (2009).
    • (2009) Am. J. Gastroenterol. , vol.104 , pp. 3081-3083
  • 10
    • 0037347305 scopus 로고    scopus 로고
    • Bismuth-based quadruple therapy using a single capsule of bismuth biskalcitrate, metronidazole, and tetracycline given with omeprazole versus omeprazole, amoxicillin, and clarithromycin for eradication of H. pylori in duodenal ulcer patients: A prospective, randomized, mulicenter, north American trial
    • Laine, L. et al. Bismuth-based quadruple therapy using a single capsule of bismuth biskalcitrate, metronidazole, and tetracycline given with omeprazole versus omeprazole, amoxicillin, and clarithromycin for eradication of H. pylori in duodenal ulcer patients: a prospective, randomized, mulicenter, north American trial. Am. J. Gastroenterol. 98, 562-567 (2003).
    • (2003) Am. J. Gastroenterol. , vol.98 , pp. 562-567
    • Laine, L.1
  • 11
    • 0023867424 scopus 로고
    • Prevention of nitroimidazole resistance in Campylobacter pylori by coadministration of colloidal bismuth subcitrate: Clinical and in vitro studies
    • Goodwin, C. S. et al. Prevention of nitroimidazole resistance in Campylobacter pylori by coadministration of colloidal bismuth subcitrate: clinical and in vitro studies. J. Clin. Pathol. 41, 207-210 (1988).
    • (1988) J. Clin. Pathol. , vol.41 , pp. 207-210
    • Goodwin, C.S.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.